Latest News for: lung cancer

Edit

AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 Billion

Wall Street Journal 14 Jul 2026
AstraZeneca entered into an exclusive global license agreement with China’s Dizal Pharmaceutical for the lung cancer treatment ... .
Edit

Immuto Scientific to Present New Conformational Target Landscape in TKI-Resistant Non-Small Cell Lung Cancer at ...

Business Wire 14 Jul 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #biotech--Immuto Scientific to Present New Structural Surfaceomics Data in TKI-Resistant Non-Small Cell Lung Cancer at Inaugural AACR D3 Conference ... .
Edit

New hope for lung cancer patients today | Opinion

Abilene Reporter News 14 Jul 2026
Too often when patients hear the words lung cancer, they automatically assume it’s a devastating diagnosis with little reason to have hope for survival ... Immunotherapy has also transformed lung cancer treatment.
Edit

Young, healthy non-smokers getting lung cancer? Experts explain why

The News International 14 Jul 2026
A 2021 study from the Epidemiology of Young Lung Cancer Project, the Genomics of Young Lung Cancer Project, also found that lung cancers diagnosed in people younger than 40 represent distinct subtypes compared with those seen in older adults.
Edit

Lung Cancer Survivor Shira Boehler & Ecosense Launch Radon-Free Campaign

GetNews 14 Jul 2026
... educating Americans about radon gas — the leading cause of lung cancer among people who never smoked — and improving access to early lung cancer screening through the newly-launched fund .
Edit

AstraZeneca enters exclusive global license agreement for novel oral EGFR inhibitor Zegfrovy for lung cancer with Dizal Pharmaceutical (Form 6-K) (AstraZeneca plc)

Public Technologies 14 Jul 2026
Lung cancer is the leading cause of cancer death among men and women, accounting for about one-fifth of all cancer deaths.2 Lung cancer is broadly split into small cell lung cancer or NSCLC, the ...
Edit

AstraZeneca enters exclusive global license agreement for novel oral EGFR inhibitor Zegfrovy for lung cancer with Dizal Pharmaceutical (AstraZeneca plc)

Public Technologies 14 Jul 2026
Lung cancer is the leading cause of cancer death among men and women, accounting for about one-fifth of all cancer deaths.2 Lung cancer is broadly split into small cell lung cancer or NSCLC, the ...
Edit

START THE WEEK OFF RIGHT: Why you should care about lung cancer

Quad-City Times 13 Jul 2026
Knowing the signs can help diagnose lung cancer at an early stage, when treatment is most successful ... .
Edit

Why are healthy young non-smokers developing lung cancer?

Science Daily 13 Jul 2026
An unexpected study found that young non-smokers with healthier ...
Edit

National Nonprofit, Local Church to Host Community Conversation on Lung Cancer, AI, and Health Equity

The Birmingham Times 13 Jul 2026
A fireside conversation featuring a lung cancer survivor and caregiver The importance of early lung cancer screening and early detection The latest advances in lung cancer treatment and precision ...
Edit

Breathing Through the Unknown: Lung Cancer, the Indian Diaspora, and New Reasons for Hope

News India Times 13 Jul 2026
Lung cancer kills more people worldwide than any other cancer—yet most of us still picture it as a smoker’s disease ... Nearly four years ago, during a routine heart health checkup, I was unexpectedly diagnosed with stage 4 lung cancer.
Edit

Years After He Quit Smoking, a Lung Cancer Scan Saved His Life

New York Times 11 Jul 2026
Lung cancer remains the leading cause of cancer deaths in the United States and older adults are at higher risk. But only about a quarter of patients eligible for screening are up-to-date ... .
×